SBIR/STTR Updates 2026
SBIR continues to grow as a critical source of non-dilutive funding for innovation-driven small businesses. As more companies look to SBIR as a pathway for early-stage research, product development, validation, and commercialization, the numbers behind each announcement are becoming especially important: funding limits, project periods, eligibility requirements, deadlines, and phase-specific expectations can directly affect strategy and competitiveness.
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) – R43/R44
This announcement covers the standard SBIR funding pathway and is intended to support small businesses developing innovative technologies, products, or services with commercial potential.
For companies considering an initial SBIR submission, this opportunity is particularly important because it provides the baseline framework for how SBIR support is structured and evaluated.
Phase I: Establish the technical merit and feasibility of the proposed R&D, and a budget of $323,090 for a project timeline between 6 months to 2 years.
With institute specific waivers, total funding support can exceed the designated SBA budgetary guidelines, going up to as high as $700,000 for Phase I
Phase II: Continue R&D to advance toward commercialization, and a budget of $2,153,927 for a project timeline between 1 to 3 years.
With institute specific waivers, total funding support can exceed the designated SBA budgetary guidelines, going up to as high as $3,000,000 for Phase II
NIH Fast-Track: The NIH Fast-Track allows both Phase I and Phase II of a project to be submitted and reviewed together as one application to reduce or eliminate the funding gap between phases.
NIH Direct to Phase II: Small businesses that have already demonstrated scientific and technical merit and feasibility but have not received a Phase I SBIR or STTR for that project, can apply for a Direct to Phase II award.
STTR Equivalent: NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) – The STTR grant program helps US small business who partner with a nonprofit research institutions bring scientific innovations to the marketplace.
Approaching Deadline: September 5, 2026
Upcoming Deadlines: January 5, 2027 and April 5, 2027
| NIH Participating Component | Phase I Budget | Phase II Budget |
| National Cancer Institute | $700,000.00 | $2,500,000.00 |
| National Eye Institute | $400,000.00 | SBA Guideline |
| National Heart, Lung, and Blood Institute | $400,000.00 | $3,000,000.00 |
| National Human Genome Research Institute | $400,000.00 | SBA Guideline |
| National Institute on Aging | $700,000.00 | $3,000,000.00 |
| National Institute on Alcohol Abuse and Alcoholism | $400,000.00 | $2,500,000.00 |
| National Institute of Allergy and Infectious Diseases | $700,000.00 | $3,000,000.00 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | SBA Guideline | SBA Guideline |
| National Institute of Biomedical Imaging and Bioengineering | SBA Guideline | SBA Guideline |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | $400,000.00 | $2,500,000.00 |
| National Institute on Deafness and Other Communication Disorders | $400,000.00 | $3,000,000.00 |
| National Institute of Dental and Craniofacial Research | SBA Guideline | SBA Guideline |
| National Institute of Diabetes and Digestive and Kidney Diseases | $400,000.00 | $2,500,000.00 |
| National Institute on Drug Abuse | $400,000.00 | $3,000,000.00 |
| National Institute of Environmental Health Sciences | SBA Guideline | SBA Guideline |
| National Institute of General Medical Sciences | $700,000.00 | $3,000,000.00 |
| National Institute of Mental Health | $700,000.00 | $3,000,000.00 |
| National Institute of Neurological Disorders and Stroke | $700,000.00 | $3,000,000.00 |
| National Institute of Nursing Research | $400,000.00 | $2,500,000.00 |
| National Institute on Minority Health and Health Disparities | SBA Guideline | SBA Guideline |
| National Library of Medicine | SBA Guideline | SBA Guideline |
| National Center for Complementary and Integrative Health | $700,000.00 | SBA Guideline |
| National Center for Advancing Translational Sciences | SBA Guideline | SBA Guideline |
| Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs | SBA Guideline | SBA Guideline |
| Office of Research on Women’s Health | SBA Guideline | $2,500,000.00 |
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) – R44
This SBIR Phase IIB Strategic Breakthrough NOFO provides previous NIH SBIR or STTR Phase II recipients support to bridge the gap between the Phase II and commercialization. Applicants must secure 100% third-party matching funds for the proposed Phase IIB Strategic Breakthrough award project.
With institute specific waivers, total funding ranges between $3,000,000 – $15,000,000!
Approaching Deadline: September 5, 2026
Upcoming Deadlines: January 5, 2027 and April 5, 2027
| Institute or Center | Phase IIB Budget |
| National Cancer Institute | $15,000,000.00 |
| National Eye Institute | SBA Guideline |
| National Heart, Lung, and Blood Institute | $4,500,000.00 |
| National Institute on Aging | $3,000,000.00 |
| National Institute on Alcohol Abuse and Alcoholism | $4,500,000.00 |
| National Institute of Allergy and Infectious Diseases | $3,000,000.00 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | $3,000,000.00 |
| National Institute of Diabetes and Digestive and Kidney Diseases | $3,000,000.00 |
| National Institute of General Medical Sciences | $3,000,000.00 |
| National Institute of Mental Health | $3,000,000.00 |
| National Institute of Neurological Disorders and Stroke | $3,000,000.00 |
| National Institute on Minority Health and Health Disparities | SBA Guideline |
| National Center for Advancing Translational Sciences | $3,000,000.00 |
| Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs | SBA Guideline |
| Office of Research on Women’s Health | SBA Guideline |
